IniXium is a division of NuChem Sciences, a contractual research team that directly targets the structural biology needs of the pharmaceutical and biotech industry to support their discovery workflow. We are experts in protein chemistry, protein crystallization and X-ray structure determination. We offer gene to structure services as well as fragment screening, and co-structure determination to support the optimization of your lead compounds. Since August 2023, NuChem and its divisions OmegaChem & IniXium are now part of the Sygnature Discovery group.
Looking for a particular IniXium employee's phone or email?
The IniXium annual revenue was $1 million in 2026.
IniXium is based in Laval, Quebec.
The NAICS codes for IniXium are [541714, 54171, 541, 5417, 54].
The SIC codes for IniXium are [873, 87].